Proteome analysis of multidrug resistance of human oral squamous carcinoma cells using CD147 silencing

Journal of Proteome Research

Volumn 7, Issue 11, 2008, Pages 4784-4791

  Kuang, Ye Hong ^a   Chen, Xiang ^a,d   Su, Juan ^a   Wu, Li Sha ^a   Li, Ji ^a   Chang, Jing ^a   Qiu, Ying ^a   Chen, Zhe Sheng ^b   Kanekura, Takuro ^c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c ST JOHN'S UNIVERSITY   (United States)

^d CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

CD147; Human oral squamous carcinoma cells; Multidrug resistance; Proteome analysis; Rna interference

Indexed keywords

CD147 ANTIGEN; CYCLOPHILIN A; CYCLOSPORIN A; FLUOROURACIL; GLUCOSE REGULATED PROTEIN; GLUCOSE REGULATED PROTEIN 75; MATRIX METALLOPROTEINASE; PACLITAXEL; PROTEOME; RETINOIC ACID; UNCLASSIFIED DRUG; VINCRISTINE; COLORING AGENT; FORMAZAN; MTT FORMAZAN; SMALL INTERFERING RNA; TETRAZOLIUM;

ARTICLE; CANCER CELL CULTURE; CELL MEMBRANE; CHEMOSENSITIVITY; COLORIMETRY; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME SYNTHESIS; FLOW CYTOMETRY; GENE SILENCING; HUMAN; HUMAN CELL; METASTASIS; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING; DRUG RESISTANCE; GENETIC TRANSFECTION; GENETICS; METABOLISM; METHODOLOGY; PATHOLOGY; TUMOR CELL LINE;

ANTIGENS, CD147; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; COLORING AGENTS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FORMAZANS; HUMANS; PROTEOME; PROTEOMICS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TETRAZOLIUM SALTS; TRANSFECTION;

EID: 58149400654     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr800355b     Document Type: Article

References (38)

1. Gottesman, M. M.; Fojo, T.; Bates, S. E. Multidrug resistance in cancer: Role of ATP-dependent transporters. Nat Rev. Cancer 2002, 2 (1), 48-58.
2. Modok, S.; Mellor, H. R.; Callaghan, R. Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer. Curr. Opin. Pharmacol. 2006, 6 (4), 350-4.
3. Kerbel, R. S.; Waghorne, C.; Korczak, B.; Lagarde, A.; Breitman, M. L. Clonal dominance of primary tumours by metastatic cells: Genetic analysis and biological implications. Cancer Surv. 1988, 7 (4), 597-629.
4. Su, Z. Z.; Austin, V. N.; Zimmer, S. G.; Fisher, P. B. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Haras-transformed cloned rat embryo fibroblast cells. Oncogene 1993, 8 (5), 1211-9.
5. Burt, R. K.; Garfield, S.; Johnson, K.; Thorgeirsson, S. S. Transformation of rat liver epithelial cells with v-H-ras or v-raf causes expression of MDR-1, glutathione-S-transferase-P and increased resistance to cytotoxic chemicals. Carcinogenesis 1988, 9 (12), 2329-32.
6. Hennequin, E.; Delvincourt, C.; Pourny, C.; Jardillier, J. C. Expression of mdrl gene in human breast primary tumors and metastases. Breast Cancer Res. Treat. 1993, 26 (3), 267-74.
7. Miyauchi, T.; Kanekura, T.; Yamaoka, A.; Ozawa, M.; Miyazawa, S.; Muramatsu, T. Basigin, a new, broadly distributed member of the immunoglobulin superfamily, has strong homology with both the immunoglobulin V domain and the beta-chain of major histocompatibility complex class II antigen. J. Biochem. 1990, 107 (2), 316-23.
8. Kanekura, T.; Miyauchi, T.; Tashiro, M.; Muramatsu, T. Basigin, a new member of the immunoglobulin superfamily: Genes in different mammalian species, glycosyiation changes in the molecule from adult organs and possible variation in the N-terminal sequences. Cell Struct. Funct 1991, 16 (1), 23-30.
9. Miyauchi, T.; Masuzawa, Y.; Muramatsu, T. The basigin group of the immunoglobulin superfamily. Complete conservation of a segment in and around transmembrane domains of human and mouse basigin and chicken HT7 antigen. J. Biochem. 1991, 110 (5), 770-4.
10. Kanekura, T; Chen, X; Kanzaki, T. Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int. J. Cancer 2002, 99 (4), 520-8.
11. Chen, X.; Lin, J.; Kanekura, T.; Su, J.; Lin, W.; Xie, H. F.; Wu, Y. X; Li, J.; Chen, M. L.; Chang, J. A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of malignant melanoma. Cancer Res. 2006, 66 (23), 11323-30.
12. Kirk, P.; Wilson, M. C.; Heddle, C.; Brown, M. H.; Barclay, A. N.; Halestrap, A P. CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO J. 2000, 19 (15), 3896-904.
13. Yurchenko, V.; Zybarth, G.; O'Connor, M.; Dai, W. W.; Franchin, G.; Hao, T.; Guo, H.; Hung, H. C.; Toole, B.; Gallay, P.; Sherry, B.; Bukrinsky, M. V.; Zybarth, G.; O'Connor, M. Active site residues of cyclophilin A are crucial for its signaling activity via CD147. J. Biol. Chem. 2002, 277 (25), 22959-65.
14. Yang, J. M.; Xu, Z.; Wu, H.; Zhu, H.; Wu, X.; Hait, W. N. Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. Mol. Cancer Res. 2003, 1 (6), 420-7.
15. Misra, S.; Ghatak, S.; Zoltan-Jones, A.; Toole, B. P. Regulation of multidrug resistance in cancer cells by hyaluronan. J. Biol. Chem. 2003, 278 (28), 25285-8.
16. Marieb, E. A.; Zoltan-Jones, A.; Li, R.; Misra, S.; Ghatak, S.; Cao, J.; Zucker, S.; Toole, B. P. Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production. Cancer Res. 2004, 64 (4), 1229-32.
17. Yang, Y. X.; Xiao, Z. Q.; Chen, Z. C.; Zhang, G. Y.; Yi, H.; Zhang, P. F.; li, J. N.; Zhu, G. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR. Proteomics 2006, 6 (6), 2009-21.
18. Chen, X.; Su, J.; Chang, J.; Kanekura, T.; Li, J.; Kuang, Y. H.; Peng, S.; Yang, F.; Lu, H.; Zhang, J. L. A small interfering CD147-targeting RNA inhibits the proliferation, activation, adhesion and migration of Jurkat cells. Cancer Invest. 2008, 26 (7), 689-697.
19. Brummelkamp, T. R.; Bernards, R.; Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002, 296 (5567), 550-3.
20. Holen, T.; Amarzguioui, M.; Wiiger, M. T.; Babaie, E.; Prydz, H. Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res. 2002, 30 (8), 1757-66.
21. Zou, W.; Yang, H.; Hou, X.; Zhang, W.; Chen, B.; Xin, X. Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to paclitaxel in HO-8910 pm cells. Cancer Lett. 2007, 248 (2), 211-8.
22. Verrills, N. M.; Kavallaris, M. Drug resistance mechanisms in cancer cells: A proteomics perspective. Curr. Opin. Mol. Ther. 2003, 5 (3), 258-65.
23. Gehrmann, M. L.; Fenselau, C.; Hathout, Y. Highly altered protein expression profile in the adriamycin resistant MCF-7 cell line. J. Proteome Res. 2004, 3 (3), 403-9.
24. Wadhwa; Taira, K.; Kaul, S. C. Mortalin: A potential candidate for biotechnology and biomedicine. Histol Histopathol. 2002, 17 (4), 1173-7.
25. Galat, A Peptidylproline cis-trans-isomerases: Immunophilins. Eur. J. Biochem. 1993, 216 (3), 689-707.
26. Handschumacher, R. E.; Harding, M.; Rice, J.; Drugge, R. J.; Speicher, D. W. Cyclophiiin: A specific cytosolic binding protein for cyclosporin A. Science 1984, 226 (4674), 544-7.
27. Li, M.; Wang, H.; Li, F.; Fisher, W. E.; Chen, C.; Yao, Q. Effect of cyclophiiin A on gene expression in human pancreatic cancer cells. Am. J. Surg. 2005, 190 (5), 739-45.
28. Campa, M. J.; Wang, M. Z.; Howard, B.; Fitzgerald, M. C.; Patz, E. F., Jr. Protein expression profiling identifies macrophage migration inhibitory factor and cyclophiiin A as potential molecular targets in non-small cell lung cancer. Cancer Res. 2003, 63 (7), 1652-6.
29. Yurchenko; Zybarth, V. G.; O'Connor, M.; Dai, W. W.; Franchin, G.; Hao, T.; Guo, H.; Hung, H. C.; Toole, B.; Gallay, P; Sherry, B.; Bukrinsky, M. Active-site residues of cyclophilin A are crucial for its signaling activity via CD 147. J. Biol. Chem 2002, 277 (25), 22959-65.
30. Chen, S.; Zhang, M.; Ma, H.; Saiyin, H.; Shen, S.; Xi, J.; Wan, B.; Yu, L. Oligo-microarray analysis reveals the role of cyclophilin A in drug resistance. Cancer Chemother. Pharmacol. 2008, 61 (3), 459-69.
31. González-Santiago, L.; Alfonso, P.; Suárez, Y.; Núñez, A.; García- Fernández, L. F.; Alvarez, E.; Muñoz, A.; Casal, J. I. Proteomic analysis of the resistance to aplidin in human cancer cells. J. Proteome Res. 2007, 6 (4), 1286-94.
32. Yang, Y.; Zhu, P. CD147 Facilitates Cyclophiiin A-induced MMP-9 expression on monocytes/macrophages in rheumatoid arthritis. J US-China Med. Sci. 2007, 4 (3), 55-62.
33. Aouali, N.; Eddabra, L.; Macadre, J.; Morjani, H. Immunosuppressors and reversion of multidrug-resistance. Crit. Rev. Oncol. Hematol. 2005, 56 (1), 61-70.
34. Chen, J. Y.; Yan, Z.; Shen, C.; Fitzpatrick, D. P.; Wang, M. A systems biology approach to the study of cisplatin drug resistance in ovarian cancers. J. Bioinf. Comput. Biol. 2007, 5 (2a), 383-405.
35. Liu, F. T.; Rabinovich, G. A. Galectins as modulators of tumour progression. Nat. Rev. Cancer 2005, 5 (1), 29-41.
36. Chiang, W. F.; Liu, S. Y.; Fang, L. Y.; Lin, C. N.; Wu, M. H.; Chen, Y. C.; Chen, Y. L.; Jin, Y. T. Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma. Oral Oncol. 2008, 44 (4), 325-34.
37. Reichelt, J.; Breiden, B.; Sandhoff, K.; Magin, T. M. Loss of keratin 10 is accompanied by increased sebocyte proliferation and differentiation. Eur. J. Cell Biol. 2004, 83 (11-12), 747-59.
38. Chen, X.; Kanekura, T.; Kanzaki, T. Expression of basigin in human fetal, infantile and adult skin and in basal cell carcinoma. J. Cutaneous Pathol. 2001, 28 (4), 184-90.